-
Single-Molecule Screening of Fast-Dissociating Antibodies
2026-09-05
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. Fab probes derived from these antibodies supported multiplexable imaging and revealed rapid espin turnover within stable actin cores of inner-ear hair-cell stereocilia.
-
Fast-Dissociating Antibodies by Single-Molecule Screening
2026-09-04
Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes supported multiplex imaging and revealed rapid espin turnover within the dense F-actin cores of inner-ear stereocilia.
-
Acetylcholine Chloride in Gut-Brain Research
2026-09-04
Learn how Acetylcholine Chloride can serve as a controlled cholinergic stimulus for gut, vagal, neuronal, and receptor assays inspired by microbiota-mediated seizure research. The workflow combines fresh solution handling, quantitative dose-response design, and orthogonal neural readouts to distinguish acetylcholine receptor activation from broader tissue or microbiome effects.
-
LKB1, Histone Lactylation, and Senescence in LUAD
2026-09-04
The reference study identifies a metabolic–epigenetic–telomere axis through which LKB1 suppresses telomerase activity and promotes senescence in lung adenocarcinoma. Its findings connect lactate-linked histone H4 lactylation, Sp1-dependent TERT transcription, telomere dysfunction, and preclinical treatment responses, while highlighting a rationale for combining telomerase and glycolysis-directed strategies.
-
2X Taq PCR Master Mix: CRC Assay Workflows
2026-09-03
Turn genotype checks, cloning, and endpoint amplicon screening into a shorter, lower-handling workflow with integrated gel-loading dye. This guide connects the mix’s adenine-tailing chemistry to practical validation of the NEIL1–COL17A1 colorectal cancer axis while clearly separating endpoint PCR from quantitative expression analysis.
-
WZ4003: NUAK1/2 Inhibitor Workflows
2026-09-02
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase target engagement with measurable changes in MYPT1 phosphorylation, cell migration, proliferation, invasion, and tau biology. Its strongest value is workflow flexibility: the same chemical probe can support cancer-focused cell assays and carefully controlled ex vivo neurodegeneration studies.
-
Fumagillin Against Azumiobodo hoyamushi: Study Insights
2026-09-02
This study established a comparative in vitro and in vivo framework for identifying compounds active against Azumiobodo hoyamushi, the protozoan associated with soft tunic syndrome in cultured Halocynthia roretzi. Fumagillin showed moderate 24-hour antiparasitic activity, while formalin and chlorine dioxide produced the clearest reduction in parasite burden during the short in vivo treatment assessment.
-
Polygodial for TRPA1 Channel Research
2026-09-01
Polygodial provides a chemically timed way to activate TRPA1 and connect channel activity with calcium entry, NFAT signaling, and epithelial inflammatory outputs. This workflow distinguishes acute ion-channel responses from slower transcriptional effects, making it useful for sensory neuron, epithelial, and neurophysiology research.
-
Mechanisms of Propranolol in Essential Tremor
2026-09-01
A prospective observational study used transcranial magnetic stimulation and eyeblink classical conditioning to compare how primidone and Propranolol alter motor circuits in essential tremor. The results associate Propranolol with reduced corticospinal excitability and increased short afferent inhibition, supporting a central noradrenergic–GABAergic contribution alongside its established peripheral actions.
-
Atorvastatin Workflows for Mevalonate and Ferroptosis
2026-08-31
Learn how to deploy Atorvastatin as an HMG-CoA reductase inhibitor across cholesterol metabolism research, vascular assays, and ferroptosis-oriented HCC experiments. This practical guide connects stock preparation, dose-finding, mechanistic readouts, and troubleshooting while separating established product data from model-dependent research recommendations.
-
Olsalazine Sodium: From Chemotaxis to Xenobiotics
2026-08-31
Olsalazine Sodium is a mesalamine dimer that connects inflammation biology with emerging xenobiotic transport research. This article explains how its chemistry, LTB4 chemotaxis activity, and mosquito clearance findings should shape assay design without overstating cross-domain conclusions.
-
Indometacin Sodium Assay Workflows
2026-08-30
Learn how to use Indometacin Sodium as a controlled COX-1/COX-2 perturbation in inflammation assays, pancreatic stellate cell studies, and oligodendrocyte differentiation workflows. A randomized IVF study also shows why prostaglandin biology and experimental context matter when interpreting ovulation-related endpoints.
-
Latrunculin A: A Smarter Actin Assay Strategy
2026-08-29
Latrunculin A is a reversible inhibitor of actin assembly that can reveal whether cellular phenotypes depend on filament formation. This guide connects molecular mechanism, assay design, and recent virus–host evidence while emphasizing interpretation, controls, and experimental limitations.
-
Phenothiazines Enhance Macrophage Antibacterial Activity
2026-08-28
The 2025 study identifies phenothiazines as host-directed antibacterial lead compounds that strengthen macrophage control of intracellular bacteria through reactive oxygen species accumulation, lysosomal activation, and autophagy. Its inhibitor and scavenger experiments provide mechanistic support, while perphenazine treatment in a Salmonella Typhimurium model extends the findings toward in vivo infection research.
-
How NS1 Rewires DNMT1 in HBoV1 Infection
2026-08-28
Qin et al. show that human bocavirus 1 uses NS1 to promote DNMT1 degradation, thereby coordinating viral DNA methylation, genome replication, and RNA processing. The study identifies a mechanistic link between epigenetic control and parvoviral gene expression while suggesting DNMT1 as a potential antiviral research target.